ArticleGlobal health & medicine2026
Laparoscopic liver resection for patients with intrahepatic cholangiocarcinoma using data from the Japanese National Database: A nationwide observational study.
Article in Global health & medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since 2011, the Ministry of Health, Labour and Welfare (MHLW) has made the data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) available for research purposes. Recent trends in treatments and prognosis for intrahepatic cholangiocarcinoma (ICC) were analyzed using data from this comprehensive database. This repeated cross-sectional study employed NDB open data to determine the number of patients with ICC and those treated for ICC from fiscal years (FY) 2016 to 2020. The International Classification of Diseases version 10 (ICD-10) code of C22.1 (ICC) was used to define ICC patients. The number of patients diagnosed with ICC and treated in Japan did not change during the study period (FY2016: 1,119; FY2017: 1,136; FY2018: 1,213; FY2019: 1,185; FY2020: 1,194). The number of patients who underwent open liver resection (OLR) did not change either (FY2016: 748; FY2017: 771; FY2018: 807; FY2019: 760; FY2020: 753). On the other hand, patients who underwent laparoscopic liver resection (LLR) increased during the study period (FY2016: 84; FY2017: 118; FY2018: 143; FY2019: 171; FY2020: 195). This was primarily due to the increase in the number of patients who received laparoscopic liver resection larger than subsegmentectomy (FY2016, 57; FY2017, 81; FY2018, 98; FY2019, 101; FY2020, 133). The median postoperative survival was 5.25 years in the OLR group and was not reached in the LLR group. The national database analysis revealed that while the number of patients diagnosed with and treated for ICC has remained stable, the adoption of minimally invasive surgery has increased, possibly because of advancements in treatment techniques, resulting in good survival outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.